Literature DB >> 15725944

Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy.

Toshio Kikuchi1, Naoki Oka, Akimasa Koga, Hiroshi Miyazaki, Haruya Ohmura, Tsutomu Imaizumi.   

Abstract

Recent studies have indicated that caveolae are enriched in a variety of signaling molecules, some of which are associated with cardiomyocyte hypertrophy. Caveolin-3, a major constituent of cardiac caveolae, has been suggested to interact with several signaling molecules. We investigated the morphologic changes of caveolae and caveolin-3 expression in hypertrophied cardiomyocytes induced by an alpha1-adrenergic agonist. Cultured rat neonatal cardiomyocytes were used for the experiments. Phenylephrine induced cellular hypertrophy associated with an increase of the number of caveolae and an up-regulation of caveolin-3. Although PMA increased the number of caveolae and the caveolin-3 expression, the extent of these up-regulations was less than that by phenylephrine. Moreover, ionomycin increased the number of caveolae and up-regulated caveolin-3 as much as phenylephrine. Phenylephrine-induced up-regulations of caveolae and caveolin-3 expression were inhibited by BAPTA, suggesting that the intracellular Ca2+ is involved in those regulations. Inhibitors of calcineurin and Ca2+calmodulin-dependent kinase II attenuated the phenylephrine-induced up-regulation of caveolin-3. In pressure-overloaded rat hearts, caveolin-3 protein levels were increased compared with sham-operated rats. In conclusion, the number of caveolae and the expression of caveolin-3 were up-regulated in rat hypertrophied cardiomyocytes, possibly via the alterations of intracellular Ca2+ and protein kinase C.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725944     DOI: 10.1097/01.fjc.0000152029.53997.57

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

Review 2.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 3.  Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.

Authors:  Yousuke T Horikawa; Yasuo M Tsutsumi; Hemal H Patel; David M Roth
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.

Authors:  Yousuke T Horikawa; Mathivadhani Panneerselvam; Yoshitaka Kawaraguchi; Yasuo M Tsutsumi; Sameh S Ali; Ravi C Balijepalli; Fiona Murray; Brian P Head; Ingrid R Niesman; Timo Rieg; Volker Vallon; Paul A Insel; Hemal H Patel; David M Roth
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

5.  17 beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats.

Authors:  Yu-Hong Cui; Zhi Tan; Xiao-Dong Fu; Qiu-Ling Xiang; Jin-Wen Xu; Ting-Huai Wang
Journal:  Mol Biol Rep       Date:  2010-12-18       Impact factor: 2.316

6.  Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels.

Authors:  Yogananda S Markandeya; Jonathan M Fahey; Florentina Pluteanu; Leanne L Cribbs; Ravi C Balijepalli
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

7.  Caveolin-1 modifies the immunity to Pseudomonas aeruginosa.

Authors:  Mihaela Gadjeva; Catherine Paradis-Bleau; Gregory P Priebe; Raina Fichorova; Gerald B Pier
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

Review 8.  Caveolinopathies: from the biology of caveolin-3 to human diseases.

Authors:  Elisabetta Gazzerro; Federica Sotgia; Claudio Bruno; Michael P Lisanti; Carlo Minetti
Journal:  Eur J Hum Genet       Date:  2009-07-08       Impact factor: 4.246

9.  Epigallocatechin-3-gallate-mediated cardioprotection by Akt/GSK-3β/caveolin signalling in H9c2 rat cardiomyoblasts.

Authors:  Shih-Ron Hsieh; Chen-Sen Hsu; Chen-Hua Lu; Wei-Cheng Chen; Chun-Hwei Chiu; Ying-Ming Liou
Journal:  J Biomed Sci       Date:  2013-11-19       Impact factor: 8.410

10.  The Effects of Aging on the Regulation of T-Tubular ICa by Caveolin in Mouse Ventricular Myocytes.

Authors:  Cherrie H T Kong; Simon M Bryant; Judy J Watson; Hanne C Gadeberg; David M Roth; Hemal H Patel; Mark B Cannell; Clive H Orchard; Andrew F James
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-05-09       Impact factor: 6.053

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.